Cardiogenomics Registry (CGR)

This study has suspended participant recruitment.
(Staffing resources currently being restructured)
Sponsor:
Information provided by (Responsible Party):
Piedmont Healthcare
ClinicalTrials.gov Identifier:
NCT00861575
First received: March 12, 2009
Last updated: September 4, 2013
Last verified: August 2013

March 12, 2009
September 4, 2013
February 2006
December 2020   (final data collection date for primary outcome measure)
To assess the relationship of multiple phenotypes and genotypes with cardiovascular disease [ Time Frame: Yearly ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00861575 on ClinicalTrials.gov Archive Site
To assess the impact of phenotypes and genotypes of specific patient subgroups (gender, ethnic, family history) on cardiovascular disease [ Time Frame: Yearly ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Cardiogenomics Registry
CAD Genotype and Phenotype Cardiac Catheterization Laboratory Registry

This is a continuous blood banking study that will archive plasma and blood permitting DNA and plasma analysis at a future date. Subjects are recruited at the time of a clinically required procedure and blood samples are collected and banked and used for future research. The main purpose of this study is to investigate the interaction of multiple phenotypes and genotypes and their impact on cardiovascular disease events and measures of atherosclerosis progression.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

20 mL of blood are collected and aliquots of whole blood, plasma, serum and buffy coat are stored.

Non-Probability Sample

Subjects undergoing a clinical required cardiovascular procedure

Cardiovascular Disease
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
10000
December 2020
December 2020   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • > 17 years of age
  • Undergoing a clinical required cardiovascular procedure
  • Agree to donation of blood sample
  • Provide written informed consent and Authorization for Use/Disclosure of PHI

Exclusion Criteria:

  • < 18 years of age
  • Refusal to donate a blood sample
  • Refusal to provide written informed consent and Authorization for Use/Disclosure of PHI
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00861575
PH05005
No
Piedmont Healthcare
Piedmont Healthcare
Not Provided
Principal Investigator: Sarah Rinehart, MD Piedmont Healthcare
Piedmont Healthcare
August 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP